MAPK1 and pachyonychia congenita: Furthermore, through KEGG pathway enrichment analysis and Genomes analysis, MIR‐766‐3P targeting MAPK1 modulated pancreatic cell proliferation and controlled cell cycle through MAPK/ERK pathway, thereby affecting PC biological behavior.